CD4 and rheumatoid arthritis: 36 In a study comprising 124 RA patients, those in the metformin group (Metformin + conventional therapy) showed significantly lower VAS scores, CD4+/CD8+ ratio, and CD4+ expression compared to those in the conventional therapy group after 90 days of treatment (Zhang et al.)(Table 3).